Literature DB >> 22433038

Sleep syncope: treatment with a permanent pacemaker.

Jason A Rytlewski1, John T Lee, Satish R Raj.   

Abstract

Vasovagal syncope usually occurs during upright posture, but Jardine et al. have described a variant that occurs at night. During "sleep syncope" patients are awakened from sleep with nausea, abdominal cramping, or a sense of impending diarrhea; get up; and faint in the bathroom. We report on a patient with recurrent sleep syncope (with physical injury) in whom an asystolic pause was documented during one of her "sleep syncope" spells. Implantation of a dual chamber pacemaker (5-year follow-up) "cured" her of further syncope. This is a report of pacemaker use for this unusual form of reflex syncope. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22433038      PMCID: PMC3774786          DOI: 10.1111/j.1540-8159.2012.03365.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

1.  The expectation effect and cardiac pacing for refractory vasovagal syncope.

Authors:  Sachin Sud; David Massel; George J Klein; Peter Leong-Sit; Raymond Yee; Allan C Skanes; Lorne J Gula; Andrew D Krahn
Journal:  Am J Med       Date:  2007-01       Impact factor: 4.965

2.  International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design.

Authors:  M Brignole
Journal:  Europace       Date:  2007-01       Impact factor: 5.214

3.  Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.

Authors:  F Ammirati; F Colivicchi; M Santini
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

4.  Dissection of carotid sinus hypersensitivity: the timing of vagal and vasodepressor effects and the effect of body position.

Authors:  C T Paul Krediet; David L Jardine; Wouter Wieling
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

5.  Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope.

Authors:  Michele Brignole; Richard Sutton; Carlo Menozzi; Roberto Garcia-Civera; Angel Moya; Wouter Wieling; Dietrich Andresen; David G Benditt; Panos Vardas
Journal:  Eur Heart J       Date:  2006-03-28       Impact factor: 29.983

6.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

7.  Vasovagal syncope interrupting sleep?

Authors:  C T P Krediet; D L Jardine; P Cortelli; A G R Visman; W Wieling
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.

Authors:  Stuart J Connolly; Robert Sheldon; Kevin E Thorpe; Robin S Roberts; Kenneth A Ellenbogen; Bruce L Wilkoff; Carlos Morillo; Michael Gent
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

9.  Sympatho-vagal responses in patients with sleep and typical vasovagal syncope.

Authors:  David L Jardine; C T Paul Krediet; Pietro Cortelli; Christopher M Frampton; Wouter Wieling
Journal:  Clin Sci (Lond)       Date:  2009-09-07       Impact factor: 6.124

10.  A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).

Authors:  Antonio Raviele; Franco Giada; Carlo Menozzi; Giancarlo Speca; Serafino Orazi; Gianni Gasparini; Richard Sutton; Michele Brignole
Journal:  Eur Heart J       Date:  2004-10       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.